In the general news, China jailed the scientist who edited human embryo DNA that developed into actual babies. In the U.S., it was slow over the holiday break. Not even President Trump tweeted much.
On the data front, Spectrum Pharma (SPPI) shares fell as their lung cancer trial failed.
From the FDA. Allergan (AGN) won approval for Ubrelvy (ubrogepant) to treat migraines.